PE fund ChrysCap plans to exit Indian pharma co Eris with 4x returns

Private equity fund ChrysCapital is set to make another profitable exit from its portfolio of pharmaceutical investments. The fund, which manages $2.5 billion worth of investments, is set to generate a four-fold return when it sells its investment in Ahmedabad-based drug maker Eris Lifesciences Pvt. Ltd, according to two people familiar with the plans.